nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—ALB—focal segmental glomerulosclerosis	0.965	1	CbGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000111	0.00324	CbGpPWpGaD
Acepromazine—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	0.000111	0.00324	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00011	0.00321	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00011	0.00321	CbGpPWpGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00011	0.0032	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00011	0.0032	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000108	0.00314	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000106	0.00309	CbGpPWpGaD
Acepromazine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	0.000106	0.00309	CbGpPWpGaD
Acepromazine—Thioproperazine—ALB—focal segmental glomerulosclerosis	0.000105	0.234	CrCbGaD
Acepromazine—ADRA1B—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000105	0.00306	CbGpPWpGaD
Acepromazine—Thiothixene—ALB—focal segmental glomerulosclerosis	0.000103	0.23	CrCbGaD
Acepromazine—Pipotiazine—ALB—focal segmental glomerulosclerosis	0.000103	0.23	CrCbGaD
Acepromazine—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000103	0.003	CbGpPWpGaD
Acepromazine—HTR2A—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.000102	0.00298	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000101	0.00293	CbGpPWpGaD
Acepromazine—ADRA1A—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.0001	0.00291	CbGpPWpGaD
Acepromazine—DRD1—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	9.98e-05	0.00291	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	9.97e-05	0.00291	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	9.85e-05	0.00287	CbGpPWpGaD
Acepromazine—HTR1A—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	9.85e-05	0.00287	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	9.77e-05	0.00285	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	9.67e-05	0.00282	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	9.61e-05	0.0028	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	9.52e-05	0.00277	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	9.43e-05	0.00275	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	9.41e-05	0.00274	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	9.32e-05	0.00272	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	9.13e-05	0.00266	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	9.1e-05	0.00265	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	8.98e-05	0.00262	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	8.94e-05	0.00261	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	8.94e-05	0.00261	CbGpPWpGaD
Acepromazine—DRD2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	8.64e-05	0.00252	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	8.58e-05	0.0025	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	8.47e-05	0.00247	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	8.35e-05	0.00243	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	8.28e-05	0.00241	CbGpPWpGaD
Acepromazine—Clomipramine—ALB—focal segmental glomerulosclerosis	8.18e-05	0.182	CrCbGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	8.15e-05	0.00237	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	8.07e-05	0.00235	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	7.98e-05	0.00233	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.95e-05	0.00232	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	7.83e-05	0.00228	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	7.53e-05	0.0022	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	7.46e-05	0.00217	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	7.44e-05	0.00217	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	7.32e-05	0.00213	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	7.28e-05	0.00212	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	7.24e-05	0.00211	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	7.18e-05	0.00209	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	7.17e-05	0.00209	CbGpPWpGaD
Acepromazine—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	7.02e-05	0.00205	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	6.93e-05	0.00202	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	6.87e-05	0.002	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	6.84e-05	0.00199	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	6.84e-05	0.00199	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	6.76e-05	0.00197	CbGpPWpGaD
Acepromazine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	6.69e-05	0.00195	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	6.62e-05	0.00193	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.61e-05	0.00193	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.57e-05	0.00192	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	6.46e-05	0.00188	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	6.31e-05	0.00184	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	6.29e-05	0.00183	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	6.26e-05	0.00183	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	6.23e-05	0.00181	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	6.2e-05	0.00181	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	6.15e-05	0.00179	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	6.09e-05	0.00177	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	6.08e-05	0.00177	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	5.96e-05	0.00174	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	5.96e-05	0.00174	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	5.93e-05	0.00173	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	5.93e-05	0.00173	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	5.88e-05	0.00171	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.77e-05	0.00168	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	5.69e-05	0.00166	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	5.68e-05	0.00165	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	5.65e-05	0.00165	CbGpPWpGaD
Acepromazine—Chlorpromazine—ALB—focal segmental glomerulosclerosis	5.61e-05	0.125	CrCbGaD
Acepromazine—ADRA1B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	5.6e-05	0.00163	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	5.57e-05	0.00162	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.53e-05	0.00161	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	5.5e-05	0.0016	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	5.47e-05	0.00159	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	5.42e-05	0.00158	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	5.41e-05	0.00158	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	5.41e-05	0.00158	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	5.38e-05	0.00157	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	5.38e-05	0.00157	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.32e-05	0.00155	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.31e-05	0.00155	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	5.3e-05	0.00154	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	5.27e-05	0.00154	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	5.23e-05	0.00153	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	5.23e-05	0.00153	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	5.17e-05	0.00151	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	5.15e-05	0.0015	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	5.15e-05	0.0015	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	5.14e-05	0.0015	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	5.08e-05	0.00148	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.08e-05	0.00148	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.06e-05	0.00147	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	5.04e-05	0.00147	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	4.99e-05	0.00146	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	4.99e-05	0.00145	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	4.98e-05	0.00145	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	4.96e-05	0.00145	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	4.93e-05	0.00144	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	4.91e-05	0.00143	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	4.88e-05	0.00142	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	4.81e-05	0.0014	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	4.79e-05	0.0014	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	4.78e-05	0.00139	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	4.75e-05	0.00139	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	4.75e-05	0.00138	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.72e-05	0.00138	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	4.67e-05	0.00136	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	4.6e-05	0.00134	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	4.57e-05	0.00133	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	4.57e-05	0.00133	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	4.56e-05	0.00133	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	4.53e-05	0.00132	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	4.52e-05	0.00132	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	4.43e-05	0.00129	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	4.35e-05	0.00127	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	4.35e-05	0.00127	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.29e-05	0.00125	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	4.2e-05	0.00123	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	4.17e-05	0.00122	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	4.14e-05	0.00121	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	4.14e-05	0.00121	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	4.11e-05	0.0012	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.06e-05	0.00118	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	4.05e-05	0.00118	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	4.02e-05	0.00117	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	4.01e-05	0.00117	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.95e-05	0.00115	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.92e-05	0.00114	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.91e-05	0.00114	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.88e-05	0.00113	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.87e-05	0.00113	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.86e-05	0.00113	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.84e-05	0.00112	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.82e-05	0.00111	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.76e-05	0.00109	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.69e-05	0.00107	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.68e-05	0.00107	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.56e-05	0.00104	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.56e-05	0.00104	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.52e-05	0.00103	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.51e-05	0.00102	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.51e-05	0.00102	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.43e-05	0.001	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.38e-05	0.000985	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.37e-05	0.000982	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.36e-05	0.000979	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.34e-05	0.000974	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.28e-05	0.000957	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.27e-05	0.000952	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.24e-05	0.000943	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.21e-05	0.000935	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.2e-05	0.000932	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.18e-05	0.000928	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.18e-05	0.000927	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.12e-05	0.000909	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.11e-05	0.000908	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	3.11e-05	0.000908	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.06e-05	0.000892	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	3.06e-05	0.000891	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	3.02e-05	0.00088	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.01e-05	0.000877	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.99e-05	0.000871	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.96e-05	0.000862	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.95e-05	0.00086	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.93e-05	0.000855	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.91e-05	0.000849	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.91e-05	0.000848	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.9e-05	0.000846	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.89e-05	0.000841	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.85e-05	0.000831	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.84e-05	0.000828	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.83e-05	0.000823	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.81e-05	0.000818	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.69e-05	0.000783	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.67e-05	0.000779	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.64e-05	0.00077	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.59e-05	0.000754	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.57e-05	0.000749	CbGpPWpGaD
Acepromazine—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	2.57e-05	0.000749	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	2.54e-05	0.000741	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.53e-05	0.000738	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.47e-05	0.000719	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.46e-05	0.000716	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.45e-05	0.000713	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.43e-05	0.000707	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.38e-05	0.000692	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—LPL—focal segmental glomerulosclerosis	2.34e-05	0.000683	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.33e-05	0.000678	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	2.26e-05	0.000659	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.25e-05	0.000657	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.22e-05	0.000647	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.18e-05	0.000635	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.17e-05	0.000633	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.11e-05	0.000616	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.1e-05	0.000613	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.08e-05	0.000607	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.07e-05	0.000604	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.01e-05	0.000586	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AGT—focal segmental glomerulosclerosis	2e-05	0.000584	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2e-05	0.000583	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.94e-05	0.000566	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.91e-05	0.000557	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.91e-05	0.000555	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.88e-05	0.000548	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.85e-05	0.000541	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.84e-05	0.000537	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.83e-05	0.000532	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.81e-05	0.000527	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.79e-05	0.000521	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.76e-05	0.000512	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.73e-05	0.000504	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.72e-05	0.000502	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.69e-05	0.000493	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.67e-05	0.000487	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.62e-05	0.000471	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.61e-05	0.000468	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.59e-05	0.000464	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.59e-05	0.000463	CbGpPWpGaD
Acepromazine—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	1.57e-05	0.000457	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.56e-05	0.000455	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.54e-05	0.000448	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.53e-05	0.000446	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.47e-05	0.000427	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.44e-05	0.000421	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.41e-05	0.000412	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.39e-05	0.000405	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	1.34e-05	0.000391	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.32e-05	0.000386	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.24e-05	0.000361	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.22e-05	0.000356	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.2e-05	0.00035	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.18e-05	0.000343	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.06e-05	0.00031	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.02e-05	0.000297	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.01e-05	0.000295	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.35e-06	0.000272	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.2e-06	0.000268	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9e-06	0.000262	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.77e-06	0.000256	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.35e-06	0.000244	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.7e-06	0.000224	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.58e-06	0.000221	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.42e-06	0.000216	CbGpPWpGaD
